Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ketteler

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Clinical Nephrology|December 11, 2025
Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysisNicolaus Mussmaecher, Steffen Mitzner, Christian Haas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2018
Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort studyLuca Neri, Ursula Kreuzberg, Francesco Bellocchio, et al.
Circulation|March 29, 2006
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul StudyJoachim H Ix, Michael G Shlipak, Vincent M Brandenburg, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|April 16, 2018
Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patientsStuart M Sprague, Markus Ketteler, Adrian C Covic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2007
Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in miceRalf Westenfeld, Cora Schäfer, Ralf Smeets, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2010
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony studyHenrik Ekberg, Corrado Bernasconi, Jana Nöldeke, et al.
Journal of Hypertension|March 27, 2003
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritisHarm Peters, Matthias Rückert, Jens Gaedeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2020
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammationJürgen Floege, Felix Funk, Markus Ketteler, et al.
Kidney International|February 19, 2002
Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritisRalf Westenfeld, Alexander Gawlik, Emile de Heer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxideAdrian C Covic, Jürgen Floege, Markus Ketteler, et al.
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Clinical Nephrology|December 11, 2025
Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysisNicolaus Mussmaecher, Steffen Mitzner, Christian Haas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2018
Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort studyLuca Neri, Ursula Kreuzberg, Francesco Bellocchio, et al.
Circulation|March 29, 2006
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul StudyJoachim H Ix, Michael G Shlipak, Vincent M Brandenburg, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|April 16, 2018
Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patientsStuart M Sprague, Markus Ketteler, Adrian C Covic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2007
Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in miceRalf Westenfeld, Cora Schäfer, Ralf Smeets, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2010
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony studyHenrik Ekberg, Corrado Bernasconi, Jana Nöldeke, et al.
Journal of Hypertension|March 27, 2003
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritisHarm Peters, Matthias Rückert, Jens Gaedeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2020
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammationJürgen Floege, Felix Funk, Markus Ketteler, et al.
Kidney International|February 19, 2002
Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritisRalf Westenfeld, Alexander Gawlik, Emile de Heer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxideAdrian C Covic, Jürgen Floege, Markus Ketteler, et al.
Pageof 22